VCA Stocks

FlowCardia, Inc., a medical device company developing endovascular devices for coronary and peripheral chronic total occlusion (CTO) recanalization, today announced it has raised $30 million in Series C financing “FlowCardia has developed a simple, safe and effective device that has the potential to dramatically improve outcomes in the interventional treatment of coronary and peripheral CTOs,”